NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES

The present invention discloses compounds according to Formula I:wherein R1a, R1b, R1c, R2a, W1, W2, X1, X2, X3, Y, and Z are as defined herein.The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using th...

Full description

Saved in:
Bibliographic Details
Main Authors TIRERA, Amynata, ALVEY, Luke, Jonathan, DUTHION, Béranger, DESROY, Nicolas, BONNATERRE, Florence, Marie-Emilie, TEMAL-LAÏB, Taoues, BUCHER, Denis, PEIXOTO, Christophe, JARY, Hélène, Marie
Format Patent
LanguageEnglish
French
German
Published 03.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention discloses compounds according to Formula I:wherein R1a, R1b, R1c, R2a, W1, W2, X1, X2, X3, Y, and Z are as defined herein.The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, fibrotic diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformation, diseases involving impairment of bone turnover, diseases associated with hypersecretion of IL-6, diseases associated with hypersecretion of TNFα, interferons, IL-12 and/or IL-23, respiratory diseases, endocrine and/or metabolic diseases, cardiovascular diseases, dermatological diseases, and/or abnormal angiogenesis associated diseases by administering the compound of the invention.
Bibliography:Application Number: EP20200728465